Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan in Hyponatremic Cancer Patients
NCT01199198Phase 4Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2011
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hyponatremia comparing Tolvaptan Group with Placebo Group (2 arms). Primary endpoint: Participants Whose Serum Sodium Concentration Corrected to at Least 135 mEq/L at Day 14. Started May 2011; status: completed.
02
Drugs
tolvaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT01199198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01199198.